| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Moderna, Inc. (MRNA) have been net sellers, shedding 696,497 shares worth roughly $62.6M on balance. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
The insider who sold still holds shares after the sale. MRNA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.44M | $1.43B | - | |
| Pres | 1.64M | $362.86M | -78,369 | |
| Other | 81.3K | $18.03M | - | |
| CFO | 60.1K | $13.33M | - | |
| Dir | 32.8K | $7.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | Hoge Stephen74 | President | Sale+OE10b5-1 | 255 | $120.96 | $30,844.11 | - | -28.1% | -79.3% | |
| May 8, 2024 | Afeyan Noubar74 | Director | Sell10b5-1 | 15,000 | $121.68 | $1,825,220.27 | -0.7% | -32.5% | -80.0% | |
| May 1, 2024 | Afeyan Noubar74 | Director | Sell10b5-1 | 15,000 | $110.92 | $1,663,854.71 | -0.7% | +6.6% | -75.7% | |
| Apr 24, 2024 | Afeyan Noubar74 | Director | Sell10b5-1 | 15,000 | $108.32 | $1,624,835.94 | -0.7% | +11.4% | -74.8% | |
| Apr 17, 2024 | Afeyan Noubar74 | Director | Sell10b5-1 | 15,000 | $103.38 | $1,550,703.28 | -0.7% | +21.0% | -76.1% | |
| Apr 15, 2024 | Hoge Stephen74 | President | Sell10b5-1 | 15,000 | $105.02 | $1,575,300.00 | -1.0% | +17.0% | -74.7% | |
| Apr 10, 2024 | Afeyan Noubar74 | Director | Sell10b5-1 | 15,000 | $107.12 | $1,606,865.00 | -0.7% | +8.3% | -77.1% | |
| Apr 8, 2024 | Mock James M85 | Chief Financial Officer | Sale+OE10b5-1 | 705 | $101.93 | $71,859.31 | -12.3% | +10.8% | -76.6% | |
| Apr 3, 2024 | Afeyan Noubar74 | Director | Sell10b5-1 | 15,000 | $101.68 | $1,525,268.12 | -0.7% | +15.7% | -74.6% | |
| Mar 27, 2024 | Afeyan Noubar74 | Director | Sell10b5-1 | 15,000 | $109.06 | $1,635,864.09 | -0.7% | +24.4% | -71.0% |